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The rat pancreatic “B-13” acinar cell is a stable progenitor cell line that differentiates into hepatocyte-like 
cells (B-13/H cells) in 2D un-coated plastic culture with simple culture media in response to 
glucocorticoid exposure.  Examination of cytochrome P450 indicated that the expression of a range of 
genes were similar to freshly isolated hepatocytes and that these gene products were functional on the 10 
basis of spectrophotometrically-detectable reduced carbon-monoxide haemoprotein and metabolism of 
several drugs.  Since normal hepatocytes readily de-differentiate under similar conditions, we 
hypothesized that B-13 cells have undergone a variety of alterations that stabilise a progenitor phenotype 
and restrict differentiation to hepatocytes only (which if capitulated in human cells, could generate a 
readily accessible supply of functional human hepatocytes in vitro).  To examine this hypothesis, the B-13 15 
karyoptype; pluripotency-inducing transcription factor expression and forced over-expression of these 
factors in B-13 cells were examined.  B-13 cells were also injected into NOD/SCID mice and engraftment 
and differentiation assessed by RT-PCR, Western blotting, immunohistochemistry and fluorescent in situ 
hybridization (FISH).  B-13 cells expressed four pluripotency-inducing transcription factors c-Myc, Klf4, 
Oct4 and Sox2 with only c-Myc expression maintained after glucocorticoid treatment.  Over-expression 20 
of the pluripotency-inducing transcription factors blocked B-13/H formation in response to 
glucocorticoid.    Injection of B-13 cells into NOD/SCID mice resulted in their engraftment to the 
pancreas and liver, with restricted differentiation to hepatocytes in the liver.  The cells did not engraft to 
any other tissues examined.  The ability of B-13 cells to specifically generate functional hepatocytes in 
vitro in response to glucocorticoid is therefore associated with genetic rearrangements that may facilitate 25 
expression of genes associated with plasticity (without leading to pluripotency), which are repressed by 
glucocorticoid treatment. 
Introduction 
There is currently considerable effort directed towards generating 
human hepatocytes from stem cells since these would have both 30 
basic science (e.g. drug metabolism and toxicity screening) and 
clinical (e.g. incorporation into bio-artificial liver devices) 
applications).1  However, embryonic stem cells (ESCs) and 
induced pluripotent stem cells have so far failed in their ability to 
generate cells with comparable function to human hepatocytes in 35 
vitro2-4, even after forced over-expression of liver transcription 
factors.5 
 One alternative to using stem cells as a source for hepatocytes, 
is to use progenitor cells.  In the liver, a bi-potential population of 
progenitor cells located within the ductal regions of the lobule is 40 
known to exist although harnessing this resource to generate 
hepatocytes in vitro has yet to be realised because there is little 
understanding of how to control their differentiation in vitro.6  
The pancreas - which is developmentally closely related to the 
liver - also contains a ductal progenitor cell.7  The rat pancreatic 45 
progenitor "B-13" cell line appears to be related to this pancreatic 
ductal progenitor cell.  Critically however, B-13 cells appear to 
be the only cells capable of generating functional hepatocytes 
(referred to as B-13/H cells) in vitro.8-11  B-13 differentiation into 
hepatocytes is achieved in a highly cost-effective manner, 50 
requiring the addition of a simple glucocorticoid hormone 
treatment.1,8-11  B-13/H cells are formed on a simple plastic sub-
stratum and, in contrast to normal primary hepatocytes, they 
remain differentiated for at least several weeks.1   
 55 
 
This contrasts markedly with normal primary rat hepatocytes 
cultured under the same conditions, which lose most hepatic 
functions within 2 – 3 days of isolation.1 
 Over the last few years, we have attempted to place the B-13 60 
glucocorticoid response into a physiological context, since a 
human equivalent would have significant scientific and clinical 
value.  We have shown that treating rats with a synthetic 
glucocorticoid results in the appearance of acinar cells which 
stain positive for the expression of hepatocyte markers.12  In mice 65 
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with high circulating levels of endogenous glucocorticoid (that 
gives rise to Cushing's disease-like symptoms by adulthood), a 
large proportion of the acinar pancreas expressed genes normally 
restricted to hepatocytes.13  In a third of these mice, 
malabsorption developed because of a loss in pancreatic exocrine 5 
function.1,13   
 We hypothesized that the uniquely effective differentiation of 
B-13 cells to B-13/H cells is associated with genetic alterations in 
the cells that have resulted in a stable progenitor phenotype for at 
least 17 years (the cells were first derived in the mid 1990s14) and 10 
an ability to overcome the three hurdles required to generate 
hepatocytes in vitro.  The data in this paper show that B-13/H 
cells express similar levels of cytochrome P450 to normal 
hepatocytes, and that the cytochrome P450 proteins have 
incorporated protoporphyrin IX and functionality.  The B-13 cells 15 
which generate these cells had a range of cytogenetic alterations 
but these alterations did not result in cells that could proliferate in 
the absence of anchorage in vitro.  The data also indicate that B-
13 cells retain an apparent bias in their ability to engraft into 
tissues, engrafting to any significant extent only into the pancreas 20 
(the probable tissue of origin15) and the liver. 
 
Results 
B-13 cells give rise to B-13/H cells in response to 
glucocorticoid with comparable hepatocyte levels of 25 
functional cytochrome P450 
Previous reports have demonstrated that B-13 cells undergo a re-
programming in gene expression that results in the expression of 
a variety of genes associated with hepatocytes.1,8-11  Figure 1 
confirms these data in cells used in the current studies, 30 
demonstrating an early induction of Sgk1 mRNA expression prior 
to an induction in Cebp-α and Cebp-β, which increased prior to 
and simultaneously respectively with the increase in the 
expression of hepatocyte marker Cyp2e1, Cps1 and albumin 
mRNAs (Figure 1A).  The increased expression of Cyp2e1, Cps1 35 
and Cepb-β (and other markers, not shown) was observed in the 
majority of cells by day 14 of treatment with DEX (Figure 1B) 
and to detectable levels of carbon monoxide reduced 
haemoprotein (Figure 1C) that are similar to those found in 
freshly isolated rat hepatocytes (Table 1).  Functional drug 40 
metabolising activity in B-13/H cells was confirmed through the 
addition of a range of drugs to the culture media and detection of 
metabolites (Figure 1D). 
 
B-13 cells are male cells with chromosomal abnormalities that 45 
constitutively express pluripotency inducing transcription 
factors but do not grow in soft agar 
B-13 cells were cloned from the AR42J cell line in the mid 
1990s14 and have been extensively expanded in culture for at least 
17 years.  Since this time, the cell line has retained both its 50 
proliferative capacity and differentiation response to 
glucocorticoid, suggestive of genetic alterations that confer a 
stable phenotype.  To confirm if any genetic changes have 
occurred, the B-13 karyotype was therefore compared to cultured 
rat liver myofibroblasts (as a normal control) and the human 55 
hepatoma HepG2 cancer cell line (as with B-13 cells, both were 
similarly proliferative under the culture conditions outlined in the 
methods section).  Analysis of each cell karyotype is summarized 
in Table 2.  These data show that liver myofibroblasts had 42 
chromosomes/cell (the normal rat diploid complement of 60 
chromosomes) whereas B-13 cells had 84 chromosomes and were 
near-tetraploid.  In contrast, cancer HepG2 cells had an abnormal 
and variable number of chromosomes compared to a normal 
human cell.  Figure 2A shows a typical karyotype from B-13 cells 
and illustrates that there were a number of structural 65 
abnormalities evident, resulting in the identity of several 
chromosomes being ambiguous (Table 3). 
 Since four transcription factors – c-Myc, Klf-4, Oct-4 and 
Sox-2 – have been shown to induce pluripotency in cells,7,16,17 the 
effect of DEX on their expression was examined.  Figure 2B 70 
shows that all 4 transcription factors were detectable in B-13 cells 
and that expression of Klf4, Oct4 and Sox2 were suppressed in B-
13/H cells, suggesting a potential role of these factors in B-13 cell 
phenotype and/or regulation in the differentiation to B-13/H cells.  
To test this hypothesis, B-13 cells were stably transfected with a 75 
construct encoding a transposase which catalyses the 
incorporation of piggybac vectors into genomic DNA.  After 
generation of this cell line (B-13trans), B-13trans cells were 
transfected with PB-CA-rTA Adv and PB-TET-MKOS and cell 
lines stably transfected with these constructs isolated.  To confirm 80 
stable piggybac-directed transgene expression, 3 B-13piggy cell 
lines were screened through treatment with doxycycline (DOX) 
to induce expression of the four mouse pluripotency-inducing 
transcription factors.18,19  RT-PCR was used to screen for murine 
c-Myc induction (note, amino acid-coding mouse and rat Klf4, 85 
Oct4 and Sox2 transcripts are highly homologous and primers 
could not distinguish between them).  Figure 2C demonstrates 
induction of c-Myc transgene expression after DOX treatment 
(after DNase I treatment of RNA to avoid amplification of 
genomic c-Myc DNA) in a line successfully generated through 90 
this strategy.  Figure 2D and E demonstrate that B-13piggy cells 
retained their response to DEX treatment and differentiated into 
B-13/H cells as determined morphologically and through 
induction of liver-specific gene expression.  Treatment with DOX 
to induce expression of the pluripotency inducing transcription 95 
factors resulted in a change of B-13piggy to a more fibroblastic 
phenotype.  DOX and DEX treatment resulted in significant cell 
death (Figure 2D) with the surviving cells remaining resistant to 
differentiation into B-13/H cells (Figure 2E).   Note, that B-13 
differentiation into B-13/H cells was also accompanied with ~ 10-100 
20% cell death (data not shown). 
 Normal cell proliferation requires anchorage to a sub-stratum.  
In contrast, tumourigenic cells proliferate without the requirement 
for anchorage to a substratum.  Figure 2F demonstrates that B-13 
cells failed to proliferate in soft agar similarly to liver 105 
myofibroblasts, which both proliferated in serum-containing 
media in vitro.  In contrast, the human hepatoma HepG2 cell line 
– used as a positive control - continued to proliferate in soft agar. 
 
B-13r cells retain differentiation potential to form hepatocytes 110 
in vitro 
To aid in the tracking of B-13 cells in NOD/SCID mice, B-13 
cells were stably transfected with a construct that encodes the 
constitutive expression of a red fluorescent protein, to generate 
the B-13r cell line.  Figure 3A-B demonstrate that B-13r cells 115 
retained the morphological change and red fluorescent protein 
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expression when converted into B-13/Hr cells through treatment 
with DEX, although the DsRed protein was localized less to the 
nucleus in  
B-13/Hr cells and was present to a greater degree in the 
cytoplasm when compared to B-13r cells.  B-13r cells also 5 
retained their ability to differentiate into functional hepatocytes in 
response to DEX treatment at the level of mRNA (Figure 3C) and 
protein (Figure 3D).  B-13/Hr cells retained a degree of pancreatic 
amylase expression (Figure 3C and 3D) with the majority of B-
13/Hr cells expressing liver markers albumin and Cyp2e1 10 
compared to undetectable levels of expression of these genes in 
B-13r cells (Figure 3C and 3D).  DsRed fluorescence is therefore 
likely also to be expressed in B-13r cells which differentiate into 
B-13/Hr cells in vivo. 
 15 
B-13r cells engraft into the pancreas and liver of female 
NOD/SCID mice 
To determine whether B-13 cells engraft into tissues in vivo, B-
13r cells were injected into female NOD/SCID mice.  Using the 
DsRed transgene as a marker, B-13r cells were identified in both 20 
the liver and pancreas (Figure 4A), but were not observed in any 
other tissues examined (lung, heart, brain, bone marrow, thymus, 
spleen, kidney and adipose tissue - data not shown).  Since 
amylase expression is retained in B-13/Hr cells expressing 
hepatocyte markers in vitro (see Figure 3C and 3D), expression 25 
of amylase was employed as a marker to screen tissues from 
NOD/SCID mice injected with B-13r cells.  Using RT-PCR 
primers specific for the rat amylase transcript (rAmylase), Figure 
4B shows that B-13r cells engrafted into both the livers and 
pancreata of both control and paracetamol pre-treated mice, but 30 
not in other tissues.   Interestingly, primers specific for the rat 
cyp2e1 transcript (rCyp2e1) show this transcript was detectable 
in the livers from several mice injected with B-13r cells, 
suggesting that the cells differentiate into B-13/Hr cells in the 
liver, but not in the pancreas (or any other tissue).  The more 35 
quantitative determination by Western blotting of tissue extracts 
for amylase expression essentially confirms these data and 
indicates significant engraftment of B-13r cells into the liver but 
not other tissues (Figure 4C).  Figure 4D further confirms these 
observations, showing typical immunohistochemical staining in 40 
liver for amylase expression and comparative results in lung and 
heart.  There was also no evidence of B-13r engraftment using 
amylase as a probe in bone marrow, brain, thymus, spleen, kidney 
and adipose tissue (data not shown).  Despite the fact that 
paracetamol injures the centrilobular region of the liver lobule - 45 
zone 3 of the acinus17, B-13 cells consistently engrafted into the 
periportal region of the lobule in both control and paracetamol 
pre-treated mice. 
 The cytogenetic data in Figure 2A suggests that the B-13 cell 
line was derived from a male rat since all the chromosomal 50 
spreads examined contained two Y chromosomes (since the cells 
were tetraploid).  Figure 5A and 5B confirm that B-13 cells are 
male cells since a sequence of DNA present only on the rat Y 
chromosome was amplified from DNA isolated from either B-13 
cells or male rats (but not from DNA isolated from female rats) 55 
and Y chromosome FISH bound only to cultured B-13 or male rat 
cells respectively.  Figure 5C and 5D confirm using FISH, that B-
13r cells engrafted into the liver since cells within the female liver 
contain the Y chromosome.  Serial sections show that the number 
of cells containing the Y chromosome is spread over a greater 60 
area of the lobule than the cells which stain for amylase.  This 
suggests that the in vivo hepatic environment is required to fully 
repress amylase expression as B-13r-derived cells are found 
further from the portal tract.  Furthermore, it suggests that B-13r 
cells differentiate into B-13/Hr cells in vivo without 65 
compromising the health of the mice. 
To confirm that engrafted B-13r cells differentiate into 
hepatocytes in vivo, liver sections from NOD-SCID mice were 
examined for the expression of DsRed and albumin by 
fluorescence microscopy.  Figure 5E indicates that DsRed cells 70 
also stained positive for albumin (supporting data from Figure 
4B), suggesting B-13 cells differentiate in B-13/Hr cells in vivo. 
 
Discussion 
These data demonstrate that B-13 cells generate functional 75 
hepatocyte-like B-13/H cells in vitro in response to 
glucocorticoid treatment.  Quantitative RT-PCR confirm for the 
first time that Sgk1 mRNA induction is one of the earliest events 
associated with glucocorticoid treatment in B-13 cells and that 
Cebp-β expression correlates with the expression of hepatic 80 
genes.  Previous work has shown that ectopic expression of 
Cebp-β alone is sufficient to induce a B-13/H-like phenotype in 
B-13 cells.8  The data presented in this work however, reports a 
prior induction of Cebp-α, which may suggest that this 
transcription factor may control earlier events in hepatic 85 
differentiation. 
 Data in this paper also demonstrate for the first time that B-13 
cells have a number of chromosomal changes (but retain a 4n 
complement of chromosomes), a feature typical of many dividing 
cells that have been propagated for some time in vitro but have 90 
not undergone transformation, such as ESC lines.20  B-13 cells 
also expressed the four pluripotency inducing transcription 
factors, c-Myc, Klf4, Oct4 and Sox2.  Previous data has shown 
that B-13 cells readily differentiate into hepatocytes but are 
resistant to de-differentiation (i.e. they maintain their hepatocyte 95 
progenitor phenotype) and do not differentiate into any other cell 
type.1,10  The data in this paper indicate that Klf4, Oct4 and Sox2 
expression falls as B-13 cells differentiate into B-13/H cells and 
suggest that a suppression of at least Klf4, Oct4 and Sox2 is 
required for differentiation, since their forced over-expression 100 
completely blocked differentiation into B-13/H cells in response 
to DEX.  Interestingly, the continued propagation of B-13piggy 
with transgene selection did not maintain the fibroblastic 
phenotype initially observed and there was a return to the B-13 
phenotype and normal B-13/H formation in response to DEX 105 
(without loss of DOX-dependent c-Myc induction, data not 
shown).  These observations suggest that the potential plasticity 
induced by over-expression of c-Myc, Klf4, Oct4 and Sox2 is 
counteracted by an unidentified factor(s) in B-13 cells, which 
may be essential for its progenitor status and restricted 110 
differentiation potential.  The identification and controlled 
expression of this factor(s) will likely be important in controlling 
progenitor cells and hepatocyte production therefrom. 
 B-13 cells also did not grow in soft agar, indicating that they 
retain a requirement for anchorage-dependent growth and 115 
responsiveness to factors which prevent un-controlled cell 
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growth.  On this basis, the cells could be defined as un-
transformed and potentially non-cancerous.  This is supported by 
the fact that B-13 cells did not give rise to tumours (or teratomas) 
when injected into NOD/SCID mice, although longer periods of 
time (> 1year) would be required to fully test this hypothesis.  5 
Interestingly, the cells appeared to specifically engraft only in the 
liver and pancreas.  Hepatic engrafted B-13 cells differentiated 
into hepatocytes and appeared to down regulate amylase 
expression (which is down-regulated but not lost when B-13 cells 
are converted to B-13/H cells in vitro) as the cells moved into the 10 
parenchyma.  In contrast, on the basis of primer pairs selective 
for rat amylase and rat Cyp2e1 transcripts, B-13 cells did not 
differentiate into hepatocytes in the pancreas despite clear 
evidence (using the rat amylase-specific transcript PCR primer 
pairs) that B-13 cells engrafted into the pancreata of mice (the 15 
high levels of degradative enzymes present in acinar pancreas 
prevented an effective FISH analysis in pancreas tissue).   
 Of fundamental importance and utility, B-13 cells are readily 
propagated in simple culture media; are expanded on plastic 
culture ware and require a single chemical hormone to drive a 20 
change in differentiation.1,10  Furthermore, the majority ( > 80%) 
of B-13 cells differentiate into B-13/H cells and express a vast 
array of liver-specific or liver-enriched genes at quantitatively 
similar levels to hepatocytes freshly isolated from rats.1,10  The 
remaining cells retain a B-13 phenotype, which likely explains 25 
why this cell line remains in existence so long after its isolation 
(i.e. factors within the culture prevent some cells from 
differentiating from the progenitor phenotype).  Although the B-
13 response mirrors a pathophysiological response of the acinar 
pancreas to elevated – Cushing’s disease levels – of 30 
glucocorticoid,13 the unique features of B-13 cell differentiation 
are likely dependent on some of the chromosomal changes that 
have occurred in this cell line.  Yet these changes may not have 
transformed the cell into a fully neoplastic phenotype. 
 Hepatocytes are a valuable resource for screening drugs and 35 
chemicals for metabolism and toxicity.1  The B-13 cell alone 
could be a valuable tool in in vitro toxicity and genotoxicity 
testing, since it retains the ability to express drug and chemical 
metabolic activity in the B-13/H phenotype.  Accordingly, the B-
13 cell has considerable “3Rs” potential since safety testing can 40 
not only be performed in vitro, but be performed without the 
requirement for animal donors.   
 
Materials and methods 
 45 
Plasmid DNA constructs   
The piggybac vectors PB-CA-rTA Adv and PB-TET-MKOS18,19 
were supplied by Dr Andras Nagy (Samuel Lunenfeld Research 
Institute, Mount Sinai Hospital, Toronto, Canada).   pCyL4321 
was obtained from Wellcome Trust Sanger Institute (Cambridge, 50 
UK).    The pDsRed2-C1 construct encoding a red fluorescent 
protein was purchased from Clontech. 
 
Cell isolation and culture 
B-13 cells and the human hepatoma HepG2 cell line were 55 
routinely cultured in Dulbecco’s minimum essential medium 
(DMEM) supplemented with 10% (v/v) foetal calf serum (FCS), 
80u/ml penicillin and 80µg/ml streptomycin.  Rat liver 
myofibroblasts were generated from the culture activation of 
quiescent hepatic stellate cells essentially as previously 60 
described.22  Myofibroblasts were cultured in DMEM containing 
4.5g/l of glucose and supplemented with 16% (v/v) FCS, 80u/ml 
penicillin and 80u/ml streptomycin.  Rat hepatocytes were 
prepared by collagenase perfusion essentially as previously 
described.9  All cells were incubated at 37oC in an humidified 65 
incubator gassed with 5% CO2 in air.   Dexamethasone (DEX) 
was purchased from the Sigma Chem Co. (Poole, UK) and was 
added to medium from 1000-fold concentrated ethanol vehicle 
solvated stocks, control cells were treated with 0.1% (v/v) ethanol 
alone as control.  Cells treated for 14 days with DEX are referred 70 
to as B-13/H cells (B-13 cells with an hepatocyte phenotype). 
 B-13 cells were transected with a variety of plasmid 
constructs using effectene (Qiagen, Southampton, UK) and stably 
transfected lines generated through repeated selection and 
expansion with antibiotics.  B-13 cells stably expressing a 75 
transposase (B-13trans) from the pCyL43 vector - required for the 
efficient incorporation of piggybac vectors into genomic DNA - 
were treated with puromycin (0.05-0.2 µg/ml).  B-13trans cells 
were then transfected with the piggybac vectors PB-CA-rTA Adv 
and PB-TET-MKOS and cells stably incorporating piggybac 80 
vectors into genome selected using G418 selection to generate B-
13piggy.  PB-CA-rTA Adv encoded the constitutive expression of 
the reverse tetracycline transactivator that is inhibited by 
doxycycline.  PB-TET-MKOS is a piggybac vector encoding the 
4 mouse pluripotency-inducing transcription factors c-Myc, Klf4, 85 
Oct4 and Sox2 under regulation of the tetO2 
tetracycline/doxycycline inducible promoter.  Piggybac transgene 
expression was induced through treatment with doxycyclin 
(DOX) at 100 µg/ml.  B-13 cells stably expressing the DsRed 
fluorescent protein (B-13r) were generated by transfection with 90 
the pDsRed2-C1 construct followed by selection using G418 (200 
– 500 µg/ml). 
 For cultures in soft agar, cells were trypsinised from the 
standard cultures and re-suspended in media containing 0.35% 
(w/v) agarose and at a concentration of 2.5 x103 cells/ml for 95 
potential to grow in soft agar essentially as previously outlined.23  
The cell/agarose mixture (1ml per well) was overlaid onto a 
solidified base layer containing cell media and 0.5% (w/v) 
agarose. Once solidified, each well was supplemented with 500µl 
of cell media to prevent drying out.  The cells were then cultured 100 
for 2 weeks, with regular additions of fresh cell media, before 
staining each well with 500µl of 0.005% (w/v) crystal violet for 1 
hour. Colonies were imaged using an Optika microscope and 
images recorded using a BUC2-500c camera (Bestscope 
International Ltd). 105 
 
RT-PCR and PCR 
Total RNA was purified using Trizol (Invitrogen, Paisley, UK) 
and RT-PCR performed and analysed essentially as previously 
outlined.10  Foetal RNA was prepared from foetuses isolated and 110 
pooled from pregnant female rats at day 12 after conception (time 
from vaginal plug formation).  Primer sequences for the 
amplification of rat cytochrome P450 2E1 (Cyp2e1), rat amylase, 
rat Cps1, rat albumin and glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh) have been published previously.10  Other 115 
primer sequences are given in Table 4.   Quantitative RT-PCR 
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employed the use of an Applied Biosystems7500 Real-Time PCR 
machine, using SYBR® Green Jumpstart™ mastermix (Sigma-
Aldrich, UK), with 2µM forward and reverse primer. Primer 
sequences are given in Table 4  
 Genomic DNA was isolated from B-13 cells and rats as 5 
previously described13 and subjected to PCR analysis for the 
presence of a non-coding X chromosome-specific sequence 
within the ZFX zinc finger protein; a non-coding Y chromosome 
specific sequence (testis-specific protein TSPY gene) and a 
control non-coding, non-sex chromosome sequence (promoter 10 
region of the rat Cyp2e1 gene).  For details of the primer 
sequences employed and the regions amplified, see Table 4. 
 
Western blotting 
Western blotting was performed essentially as previously 15 
outlined with antibodies described previously.10,11  Detection was 
achieved using an ECL kit (Amersham, UK). 
  
Immunohistochemistry 
Cultured cells were prepared by permeabilising in ice-cooled 20 
methanol for 10 minutes before washing in 1xPBS and fixing in 
2% w/v formaldehyde and 0.2% gluteraldehyde in 1xPBS pH 7.4.  
Tissues were fixed in formalin and processed for 
immunohistochemistry as previously outlined with antigen 
retrieval using 0.01M citrate buffer.24  Non-specific binding of 25 
antibodies was blocked in all samples through incubation with 
20% (v/v) bovine foetal calf serum (FCS) in 1xPBS for 20 
minutes at room temperature.  Samples were then incubated with 
primary antibodies diluted in 0.05% (v/v) FCS and left to 
incubate overnight at 4°C. Samples were washed twice in 1xPBS 30 
before applying secondary antibodies for 1 hour at RT.  
 
Drug Metabolism assays 
Total spectrophotometric cytochrome P450 was determined as 
outlined.25  Drug metabolising activity of cells in culture was 35 
determined through the addition of phenacetin, diclofenac (both 
from Sigma-Aldrich, St. Louis, MO), buproprion (Toronto 
Research Chemicals, North York, Canada) and midazolam 
(Roche, Mannheim, Germany) as a cocktail with final 
concentrations in the medium of 26µM, 9µM, 100µM and 3µM 40 
respectively.  Samples of media were taken at 1 and 3 hours after 
addition of substrates and frozen at -80°C until analysis. The 
concentrations of metabolites were analysed at Pharmacelsus 
GmbH, Saarbrücken, Germany, as previously described.26 The 
formation rate of metabolites was calculated from the slope of the 45 
regression line of the concentration-time curve.26 
 
Karyotyping 
For karyotyping, cells were expanded in culture to approximately 
75% confluency and metaphase-arrest induced by adding 50 
0.1µg/ml colchicine in fresh media for 1 hour.  The cells were 
then harvested by trypsinisation in EDTA (Sigma Chem Co, 
Poole, UK) and washed with 1xPBS (137 mM NaCl, 2.7 mM of 
KCl, 10 mM phosphate (pH 7.4)) and pelleted by centrifugation 
at 400g for 5 minutes. The cell pellet was re-suspended in 55 
0.075M KCl added dropwise up to the volume of 10ml before 
incubating the solution at 37°C for 10 minutes. The cells were 
pelleted by centrifugation and re-suspended in 5ml of ice cold 
fixative (3:1 methanol/acetic acid) with continuous gentle mixing 
to avoid clumping. Centrifugation was repeated and the cells 60 
were re-suspended in 2mls of fixative, this step was repeated 
twice.  The cells were then incubated at -20°C overnight, re-
suspended in fresh fixative and then dropped onto an angled glass 
slide under humidified conditions and left to dry in air overnight.  
The slides were then incubated in trypsin solution for 15 seconds 65 
before immediate transfer to saline solution (0.9% (w/v) NaCl) 
and then two 5 minute washes prior to staining with Wright-
Giesma staining solution (Sigma Chem Co, Poole, UK) for 4 
minutes.  The slides were then rinsed in distilled water, blot dried 
and mounted with coverslips using DPX prior to image analysis 70 
using a Zeiss Axioskop microscope with CytoVision® (Leica) 
software. 
 
Injection of B-13r cells into NOD/SCID mice 
Cultured B-13r cells were harvested by trypsinisation and washed 75 
in sterile 1x PBS before re-suspension at a concentration of 
1x106/ml in 1xPBS and injection via the tail vein of 200µl (2x105 
cells) into 10-12 week old female severe combined immune 
deficient (NOD/SCID) mice (Prkdcscid Il2rgtm1Wjl/SzJ also known 
as NOD scid gamma mice) bred in-house in the Comparative 80 
Biology Centre, Newcastle University.  NOD/SCID mice were 
pre-treated with 20mg/kg of paracetamol in 1xPBS by i.p. 
injection 3 days prior and on the day of cell injection, to stimulate 
a moderate level of liver damage.  Tissues were examined 2 
weeks after injection of cells. 85 
 
Fluorescence in Situ Hybridisation (FISH) 
FISH was carried out essentially described,27 with some 
modifications.  In brief, paraffin-embedded tissue sections were 
mounted onto coated slides and baked overnight at 55°C. Slides 90 
were de-paraffinised in 3 changes of xylene at room temperature 
for 10 minutes before dehydrating in two changes of 100% 
ethanol for 5 minutes and air drying. Sections were then 
incubated in 0.2M HCl for 20 minutes and subsequently washed 
twice in 2X saline-sodium citrate (SSC) buffer (1X SSC consists 95 
of 150mM NaCl, 340mM Na3Citrate pH 7.4) for 5 minutes, 
followed by incubation in 1M NaSCN at 80°C for 10 minutes 
before two further 5 minute washes in 2X SSC. Tissue digestion 
was performed by incubating sections at 37°C overnight with 
0.4% (w/v) pepsin in 0.001M HCl.  Sections were then washed 100 
twice in 2X SSC and air dried before re-fixation in 10% formalin 
in 1xPBS for 15 minutes. Slides were washed twice with 2X SSC 
and air dried before addition of 10µl of RatIDetectTM Chr Y 
FISH paint probe (Cambio) and sections sealed with coverslips. 
The slides were then heated to 90°C for 5 minutes to denature 105 
double stranded DNA and the probe hybridised overnight at 37°C 
in an humidified environment. After hybridization, coverslips 
were removed by soaking in 2X SSC and sections subjected to 
post-hybridisation washes twice in 2X SSC/0.1% (v/v) Tween-20 
at 45°C followed by two washes in 0.5 X SSC/0.1% (v/v) Tween-110 
20 at 45°C. Slides were briefly rinsed in H2O and air dried in the 
dark prior to staining with 4’-6’,-diamidino-2-pheylindole and 
anti-fade compound (Vectashield), coverslipping, sealing and 
microscopic examination using a Zeiss AxioImager microscope 
using excitation and emission wavelength of 611 and 631nm 115 
respectively. 
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Table 1.  Effect of various culture conditions on the levels of total CO/reduced spectrophotometrically-detectable cytochrome 
P450 in rat hepatocytes and B-13 cells. 
 
Cells [DEX] Total CYP450 
pmol/mg protein 
Total CYP420& 
pmol/mg protein 
 
 
Hepatocytes (freshly 
isolated) 
 
n/a 
 
244 ± 26 
 
493 ± 23 
    
B-13 - n/d n/d 
B-13/H 10nM 170 ± 29 400 ± 29 
 
Cell samples were washed in 1xPBS and stored as pellets at -80oC until analysis.  All data are the mean and standard deviation of at least 5 
3 separate preparations.  n/a, not applicable.  n/d, not detectable.  &Assumes haemoprotein is all CYP420. 
 This journal is © The Royal Society of Chemistry [year] Journal Name, [year], [vol], 00–00  |  9 
Table 2.  Chromosome analyses in different cell types. 
 
Cell type Spreads 
analysed 
Number of 
chromosomes 
(observed/cell -  
mean ± SD) 
Range 
(chromosomes/cel
l) 
min - max 
Mode 
(chromosomes/ce
ll) 
Number of 
chromosomes / cell 
 
B-13 
 
17 
 
82.4 ± 1.73 
 
 
79-84 
 
84 
 
84 
Myofibroblasts 11 41.6 ± 0.67 
 
40-42 42 42 
HepG2 13 75.9 ± 6.01 
 
68-83 80 variable 
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Table 3.  B-13 Karyotype. 
 
 
Chromosome no Copies positively 
identified / cell 
Abnormalities Unidentified – 
therefore 
presume marker 
chromosome 
(abnormality) 
 
Comments 
1 4 n/d   
2 3  1 1 chromosome appears to have a 
fragile site at 2q14 
3 4 n/d   
4 4 n/d   
5 4 n/d   
6 4 n/d   
7 4 n/d   
8 2 n/d 2  
9 4 n/d   
10 3 n/d 1  
11 4 n/d   
12 4 n/d   
13 4 n/d   
14 2 n/d 2  
15 2 n/d 2  
16 3 n/d 1 Marker 2?. 
17 4 n/d   
18 4 n/d   
19 4   All copies appear different 
20 4 n/d   
X 2 n/d   
Y 2 n/d   
 
n/d = none detected. 5 
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Table 4. DNA oligonucleotide sequences employed in RT-PCR and in genomic DNA PCR 
amplification. 
 
 
Oligo ID 
 
5'-3' sequence 
An’ling 
conditions 
(
o
C) 
 
 
Comments 
    
RT-PCR 
 
   
rc-MycUS TCTCGGCCGCTGCCAAACTG 58 Will amplify rat c-Myc (NM_012603.2), generating a 
fragment of 204bp 
 
rc-MycDS TGGGCGAGCTGCTGTCGTTG  
rKlf4US GGCGGGCTGATGGGCAAGTT 58 Will amplify rat Klf4 (NM_053713.1), generating a 
fragment of 235bp 
 
rKlf4DS GCTGGGGTCCAGCGCTCAAG  
rOct4US TGGTGCAGGCCCGGAAGAGA 58 Will amplify rat Oct4 (NM_001009178.1), generating a 
fragment of 180bp 
 
rOct4DS TCCCCTTCTGGCGCCGGTTA  
rSox2US CTTCCCGGAGGCTTGCTGGC 58 Will amplify rat Sox2 (NM_001109181.1), generating a 
fragment of 105bp 
 
rSox2DS CGCGTAGCTGTCCATGCGCT  
mc-MycUS TTTCTCAGCCGCTGCCAAGCTGGTCTCG 58 Selectively amplifies mouse c-Myc (NM_001177352.1), 
440bp fragment over rat c-Myc (NM_012603.2)  - 10 
nucleotide mismatches between rat and mouse transcripts 
in primer hybridisation regions (see supplementary Figure 
2). 
 
mc-MycDS GGGATGGAGATGAGCCCGACTCC 
 
 
rAmylaseUS TGTGGCTCGGGCAATAGTGCA 62 Selectively amplifies rat pancreatic amylase 2 
(NM_031502.1 )  497bp fragment over mouse pancreatic 
amylases (NM_001190403.1, NM_001042711.2, 
NM_001160150.1, NM_001160152.1, NM_001160151.1, 
XM_003084551.2) – at least 5 and upto 12 nucleotide 
mismatches between rat and mouse transcripts in primer 
hybridisation regions. 
 
rAmylaseDS CCATTCCATTTGCGAATAACTGTGCCA  
rCyp2e1US CCTGAAAACTTCCTGATATC 60 Selectively amplify rat Cyp2e1 (NM_031543.1) 86bp 
fragment over mouse cyp2e1(NM_021282.2) – 13 
nucleotide mismatches between rat and mouse transcripts 
in primer hybridisation regions. 
 
rCyp2e1DS TGATAGGAACTCTATATGCTTGGGT  
   
Genomic DNA PCR   
 
rXchromUS   
 
CTCTGAAGACAGAAGATTAGA 
  
Will amplify a 114bp intronic sequence of the rat zinc 
finger protein X-linked (Zfx) gene (NM_001109017.1 )  
specifically present on the X chromosome. 
 
rXchromDS TTGCCTTGGTCATGTGTC 50 
rYchromUS ATAGGTTTTCAGGTGTTGCCTGG 55 Will amplify a 243bp intronic sequence of the rat testis-
specific protein TSPY gene (AF074879.1) specifically 
present on the Y chromosome. 
 
rYchromDS TAATGAATGGTCAGAGAAAGCCAAC  
genomCYP2E1US AGAGGAGGGTGGACCAGTCCTGCACTCCT 55 Will amplify a 867bp promoter sequence of the rat 
CYP2E1 gene (NW_047563.2) specifically present on rat 
chromosome 1. 
 
genomCYP2E1DS CTGGGGCTCCACTGTAAACTTGTAGGAATT
TGCTG 
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Fig 1.  Production of B-13/H cells with functional drug metabolising activity.  A, Quantitative RT-PCR for the indicated transcript after 
treatment with 10nM DEX as indicated (↑), B-13/H = 14 days of treatment.  Note, x-axis is on a log10 scale.  Data are the mean and 
standard deviation of 3 separate experiments.  B, Immunocytochemistry for the indicated protein in B-13 and B-13/H cells, typical of at 
least 10 separate experiments.  C, Reduced carbon monoxide versus reduced spectrum of B-13/H cells, typical of at least 3 separate 5 
experiments.  B-13 cells did not contain detectable levels of either P420 or CYP450 (see Table 1). D, Metabolism of phenacetin, 
diclofenac, midazolam and bupropion to paracetamol, and hydroxylated products respectively.  Data are the mean and standard deviation 
of 3 separate experiments.  
   
 10 
Fig 2.  B-13 karyotype, pluripotency and growth characteristics in soft agar.  A, Karyotype from a B-13 cell after analysis using 
CytoVision®Molecular Devices) software – identifiable chromosomes are as indicated below each grouping; B, RT-PCR for the 
indicated transcript, RT control, amplification in the absence of RNA template; C, RT-PCR for mouse c-Myc expression in B-13piggy 
cells after treatment as indicated  for 14 days.  All RNA was pre-treated with DNase 1 unit/µg RNA) I followed by inactivation at 65oC 
for 10 mins prior to PCR amplification to exclude genomic DNA carryover and PCR amplification of genomic murine c-Myc transgene.   15 
Amplification from PB-TET-MKOS with or without DNase I treatment was used to confirm DNA digestion.  RT control, amplification 
in the absence of input RNA; PCR control, amplification in the absence of DNA template; D, photomicrographs of B-13piggy cells treated 
as indicated for 14 days; E, Western blot for the indicated protein  after treatment as indicated for 14 days; F, left - typical fields of view 
of the indicated cell line 14 days after seeding in soft agar, right – bargraph comparing the number of colonies observed for each cell line 
14 days after seeding in soft agar.  Data are the mean and standard deviation colonies observed from 3 separate experiments.  20 
*Significantly different number of colonies versus no cells control p > 0.05) using Student’s T test two tailed). 
 
  
Fig 3.  Generation of B-13r cells and differentiation to B-13/Hr cells in response to DEX in vitro.  A, typical light micrographs of parent 
B-13 cell line (upper) and B-13/H cells (lower) observed after 14 days treatment with 10nM DEX.  B, Fluorescence  microscopy for the 25 
indicated cell type screening for DNA using DAPI staining) and DsRed expression.  DAPI/DsRed panels are merged images.  C, RT-
PCR analysis for the indicated transcripts, RT control amplification in the absence of input RNA.  D, Western blot for expression of the 
indicated proteins.  All results presented are typical of at least 3 independent experiments. 
  
   30 
Fig 4.  B-13r cells engraft into the pancreas and liver of NOD/SCID mice.  A, Tissue sections from liver and pancreata from NOD/SCID 
mice injected with B-13r cells.  Sections were stained with DAPI and analysed for the presence of DsRed positive cells.  No DsRed 
positive cells were observed in tissue sections from mice that had not been injected with B-13r cells; B, RT-PCR for rat amylase 
(rAmylase) and rat cyp2e1 (rCyp2e1) in NOD/SCID mouse numbers refer to individual recipient mice) tissues after injection of B-13r 
cells, RT control, amplification in the absence of input RNA; C, Western blot for amylase expression in NOD/SCID mouse numbers 35 
refer to individual recipient mice) tissues after injection of B-13 cells as outlined in methods section.   D, Immunohistochemical staining 
for amylase in tissues from female NOD/SCID mice (upper panels) treated as indicated.  Lower panels, rat pancreas tissue demonstrating 
specific staining for amylase in acinar tissue.  No 1o Ab, staining performed without addition of primary anti-amylase antibody.  I, islet, 
with region expanded to right. 
  40 
   
Fig 5.  Confirmation of B-13r cell engraftment in the liver and evidence for differentiation to B-13/Hr in vivo.   A, PCR amplification 
from DNA isolated from B-13 cells, male or female rats.  Primer sequences which specifically anneal to sequences within the indicated 
chromosome are given in Table 3.  PCR control, amplification in the absence of DNA template.  B, FISH analysis for the Y chromosome 
in B-13 cells and in liver myofibroblasts isolated from male or female rats.  “– probe”, procedure undertaken in the absence of Y probe as 45 
a control.  White arrow indicates high magnification view on right of panel; C, Y chromosome FISH in liver sections prepared from the 
indicated sex and species, demonstrating that FISH is specific for male rat cells and that the probe does not hybridise to female rat cells 
or male NOD/SCID cells.  D, Serial sections immunostained for amylase (left) and Y chromosome FISH (right) in a liver section from a 
paracetamol-treated NOD/SCID mouse injected with B-13 cells; E, DAPI and albumin stained sections of liver from PBS control of B-
13r injected NOD/SCID mice imaged for the indicated marker. 50 
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